4//SEC Filing
Robb Gary Charles 4
Accession 0000950170-25-088005
CIK 0001088856other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 6:26 PM ET
Size
7.2 KB
Accession
0000950170-25-088005
Insider Transaction Report
Form 4
Robb Gary Charles
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-06-16$70.77/sh−3,185$225,402→ 13,364 total
Holdings
- 11,571(indirect: By Children)
Common Stock
- 11,571(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F2]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- [F3]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001529655
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 6:26 PM ET
- Size
- 7.2 KB